Surmodics, Inc. (SRDX)
USD 30.11
(-2.11%)
USD 30.11
(-2.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.64 Million USD | -209.61% |
| 2023 | 5.15 Million USD | 123.31% |
| 2022 | -22.09 Million USD | -429.66% |
| 2021 | 6.7 Million USD | 635.81% |
| 2020 | -1.25 Million USD | -119.34% |
| 2019 | 6.46 Million USD | 173.52% |
| 2018 | -8.79 Million USD | -223.88% |
| 2017 | 7.1 Million USD | -57.87% |
| 2016 | 16.85 Million USD | -11.68% |
| 2015 | 19.08 Million USD | 2.76% |
| 2014 | 18.57 Million USD | -1.3% |
| 2013 | 18.82 Million USD | 15.16% |
| 2012 | 16.34 Million USD | 193.29% |
| 2011 | -17.51 Million USD | -24.66% |
| 2010 | -14.05 Million USD | -124.44% |
| 2009 | 57.5 Million USD | 110.93% |
| 2008 | 27.26 Million USD | 175.39% |
| 2007 | 9.89 Million USD | -72.63% |
| 2006 | 36.16 Million USD | 1111.49% |
| 2005 | 2.98 Million USD | -71.5% |
| 2004 | 10.47 Million USD | -49.25% |
| 2003 | 20.64 Million USD | 92.74% |
| 2002 | 10.7 Million USD | 41.54% |
| 2001 | 7.56 Million USD | 41.87% |
| 2000 | 5.33 Million USD | 113.32% |
| 1999 | 2.5 Million USD | 150.0% |
| 1998 | 1 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 659 Thousand USD | 304.66% |
| 2024 Q3 | -5.36 Million USD | -914.72% |
| 2024 Q1 | -322 Thousand USD | 86.86% |
| 2023 Q1 | -7.22 Million USD | -9.31% |
| 2023 FY | 5.15 Million USD | 123.31% |
| 2023 Q3 | 21.41 Million USD | 503.92% |
| 2023 Q2 | -5.3 Million USD | 26.67% |
| 2023 Q4 | -2.45 Million USD | -111.44% |
| 2022 Q1 | -3.44 Million USD | -603.68% |
| 2022 Q2 | -4.89 Million USD | -42.31% |
| 2022 FY | -22.09 Million USD | -429.66% |
| 2022 Q3 | -7.14 Million USD | -45.8% |
| 2022 Q4 | -6.61 Million USD | 7.38% |
| 2021 FY | 6.7 Million USD | 635.81% |
| 2021 Q3 | -2.38 Million USD | -125.14% |
| 2021 Q2 | 9.48 Million USD | 10096.77% |
| 2021 Q1 | 93 Thousand USD | 104.67% |
| 2021 Q4 | -489 Thousand USD | 79.49% |
| 2020 Q4 | -1.99 Million USD | -271.22% |
| 2020 Q1 | -266 Thousand USD | -106.86% |
| 2020 Q2 | -156 Thousand USD | 41.35% |
| 2020 FY | -1.25 Million USD | -119.34% |
| 2020 Q3 | 1.16 Million USD | 846.15% |
| 2019 Q3 | 1.01 Million USD | 17.57% |
| 2019 Q1 | 712 Thousand USD | 129.17% |
| 2019 Q2 | 865 Thousand USD | 21.49% |
| 2019 FY | 6.46 Million USD | 173.52% |
| 2019 Q4 | 3.87 Million USD | 281.02% |
| 2018 Q4 | -2.44 Million USD | 60.94% |
| 2018 FY | -8.79 Million USD | -223.88% |
| 2018 Q2 | 525 Thousand USD | 182.94% |
| 2018 Q1 | -633 Thousand USD | -252.16% |
| 2018 Q3 | -6.25 Million USD | -1290.48% |
| 2017 FY | 7.1 Million USD | -57.87% |
| 2017 Q4 | 416 Thousand USD | -76.13% |
| 2017 Q3 | 1.74 Million USD | 3.94% |
| 2017 Q2 | 1.67 Million USD | -48.68% |
| 2017 Q1 | 3.26 Million USD | -19.96% |
| 2016 Q1 | 3.93 Million USD | -7.67% |
| 2016 Q3 | 6.59 Million USD | 194.51% |
| 2016 Q2 | 2.24 Million USD | -43.13% |
| 2016 Q4 | 4.08 Million USD | -38.11% |
| 2016 FY | 16.85 Million USD | -11.68% |
| 2015 Q3 | 5.85 Million USD | 48.96% |
| 2015 Q4 | 4.26 Million USD | -27.16% |
| 2015 Q1 | 5.03 Million USD | -7.36% |
| 2015 FY | 19.08 Million USD | 2.76% |
| 2015 Q2 | 3.93 Million USD | -21.89% |
| 2014 Q3 | 5.33 Million USD | 53.25% |
| 2014 Q1 | 4.32 Million USD | -22.36% |
| 2014 FY | 18.57 Million USD | -1.3% |
| 2014 Q2 | 3.48 Million USD | -19.61% |
| 2014 Q4 | 5.43 Million USD | 1.89% |
| 2013 Q3 | 4.23 Million USD | 2.64% |
| 2013 Q1 | 4.87 Million USD | 5.15% |
| 2013 Q4 | 5.57 Million USD | 31.57% |
| 2013 Q2 | 4.12 Million USD | -15.34% |
| 2013 FY | 18.82 Million USD | 15.16% |
| 2012 Q1 | 3.22 Million USD | 118.53% |
| 2012 FY | 16.34 Million USD | 193.29% |
| 2012 Q4 | 4.63 Million USD | -3.23% |
| 2012 Q3 | 4.79 Million USD | 29.93% |
| 2012 Q2 | 3.68 Million USD | 14.49% |
| 2011 FY | -17.51 Million USD | -24.66% |
| 2011 Q3 | 3.44 Million USD | 68.76% |
| 2011 Q2 | 2.04 Million USD | 383.61% |
| 2011 Q4 | -17.38 Million USD | -604.53% |
| 2011 Q1 | -720 Thousand USD | 96.02% |
| 2010 FY | -14.05 Million USD | -124.44% |
| 2010 Q3 | 2.22 Million USD | 333.19% |
| 2010 Q4 | -18.08 Million USD | -914.82% |
| 2010 Q2 | -952 Thousand USD | -134.39% |
| 2010 Q1 | 2.76 Million USD | -30.33% |
| 2009 Q3 | 4.66 Million USD | -24.82% |
| 2009 Q1 | 42.66 Million USD | 701.26% |
| 2009 Q2 | 6.2 Million USD | -85.47% |
| 2009 FY | 57.5 Million USD | 110.93% |
| 2009 Q4 | 3.97 Million USD | -14.76% |
| 2008 Q1 | 7.57 Million USD | 154.81% |
| 2008 FY | 27.26 Million USD | 175.39% |
| 2008 Q4 | 5.32 Million USD | -25.88% |
| 2008 Q3 | 7.18 Million USD | 0.04% |
| 2008 Q2 | 7.18 Million USD | -5.15% |
| 2007 Q1 | 8.1 Million USD | -11.54% |
| 2007 FY | 9.89 Million USD | -72.63% |
| 2007 Q4 | -13.81 Million USD | -283.73% |
| 2007 Q3 | 7.51 Million USD | -7.01% |
| 2007 Q2 | 8.08 Million USD | -0.3% |
| 2006 FY | 36.16 Million USD | 1111.49% |
| 2006 Q1 | 8.58 Million USD | 35.2% |
| 2006 Q2 | 8.95 Million USD | 4.35% |
| 2006 Q3 | 9.46 Million USD | 5.7% |
| 2006 Q4 | 9.16 Million USD | -3.13% |
| 2005 FY | 2.98 Million USD | -71.5% |
| 2005 Q4 | 6.34 Million USD | -30.63% |
| 2005 Q3 | 9.14 Million USD | 143.26% |
| 2005 Q2 | -21.14 Million USD | -344.83% |
| 2005 Q1 | 8.63 Million USD | 4.14% |
| 2004 FY | 10.47 Million USD | -49.25% |
| 2004 Q4 | 8.29 Million USD | 176.9% |
| 2004 Q1 | 6.28 Million USD | -8.0% |
| 2004 Q2 | 6.67 Million USD | 6.22% |
| 2004 Q3 | -10.78 Million USD | -261.53% |
| 2003 Q3 | 6.95 Million USD | 74.32% |
| 2003 Q2 | 3.99 Million USD | 39.82% |
| 2003 Q1 | 2.85 Million USD | -20.74% |
| 2003 Q4 | 6.83 Million USD | -1.8% |
| 2003 FY | 20.64 Million USD | 92.74% |
| 2002 FY | 10.7 Million USD | 41.54% |
| 2002 Q4 | 3.6 Million USD | 24.08% |
| 2002 Q3 | 2.9 Million USD | 21.72% |
| 2002 Q2 | 2.38 Million USD | 31.12% |
| 2002 Q1 | 1.81 Million USD | -35.54% |
| 2001 Q1 | 1.32 Million USD | -31.75% |
| 2001 FY | 7.56 Million USD | 41.87% |
| 2001 Q4 | 2.82 Million USD | 57.3% |
| 2001 Q3 | 1.79 Million USD | 10.2% |
| 2001 Q2 | 1.62 Million USD | 23.15% |
| 2000 Q2 | 1.15 Million USD | -4.08% |
| 2000 Q1 | 1.2 Million USD | 33.33% |
| 2000 FY | 5.33 Million USD | 113.32% |
| 2000 Q4 | 1.93 Million USD | 86.43% |
| 2000 Q3 | 1.03 Million USD | -9.73% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1999 Q3 | 800 Thousand USD | 33.33% |
| 1999 Q2 | 600 Thousand USD | 200.0% |
| 1999 FY | 2.5 Million USD | 150.0% |
| 1999 Q4 | 900 Thousand USD | 12.5% |
| 1998 FY | 1 Million USD | 0.0% |
| 1998 Q4 | 200 Thousand USD | -33.33% |
| 1998 Q2 | 300 Thousand USD | -84.21% |
| 1998 Q1 | 1.9 Million USD | 0.0% |
| 1998 Q3 | 300 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 60.692% |
| Cerus Corporation | -30.05 Million USD | 81.217% |
| OrthoPediatrics Corp. | -25.76 Million USD | 78.091% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 46.852% |
| Talis Biomedical Corporation | -66.81 Million USD | 91.551% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 67.362% |
| Inogen, Inc. | -109.38 Million USD | 94.839% |
| Spectral AI, Inc. | -12.98 Million USD | 56.523% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 90.981% |
| CVRx, Inc. | -43.1 Million USD | 86.903% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -60.006% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 54.578% |
| Orthofix Medical Inc. | -139.11 Million USD | 95.942% |
| Venus Concept Inc. | -28.3 Million USD | 80.059% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 89.552% |
| Bioventus Inc. | -81.72 Million USD | 93.093% |
| BrainsWay Ltd. | -4.92 Million USD | -14.573% |
| Envoy Medical, Inc. | -18.37 Million USD | 69.272% |
| electroCore, Inc. | -18.8 Million USD | 69.981% |
| IceCure Medical Ltd | -15.57 Million USD | 63.758% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 88.357% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 67.31% |
| MaxCyte, Inc. | -48.29 Million USD | 88.312% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 52.782% |
| Nexalin Technology, Inc. | -5.69 Million USD | 0.901% |
| PAVmed Inc | -68.79 Million USD | 91.794% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 90.02% |
| RxSight, Inc. | -50.08 Million USD | 88.729% |
| Sight Sciences, Inc. | -57.27 Million USD | 90.144% |
| SI-BONE, Inc. | -46.93 Million USD | 87.972% |
| TELA Bio, Inc. | -44.07 Million USD | 87.192% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 89.575% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 89.023% |
| LivaNova PLC | -68.49 Million USD | 91.759% |
| 908 Devices Inc. | -42.75 Million USD | 86.798% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 96.744% |
| Nemaura Medical Inc. | -9.59 Million USD | 41.169% |
| NeuroPace, Inc. | -27.17 Million USD | 79.226% |
| LENSAR, Inc. | -12.22 Million USD | 53.839% |
| Apyx Medical Corporation | -17.25 Million USD | 67.292% |
| Cutera, Inc. | -156.23 Million USD | 96.387% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 34.391% |
| BioSig Technologies, Inc. | -28.51 Million USD | 80.201% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 93.559% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 74.851% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 105.062% |
| Axonics, Inc. | -26.05 Million USD | 78.336% |
| Outset Medical, Inc. | -169.77 Million USD | 96.675% |
| IRIDEX Corporation | -10 Million USD | 43.589% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 94.829% |
| IRadimed Corporation | 20.03 Million USD | 128.175% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 31.534% |
| INVO Bioscience, Inc. | -6.76 Million USD | 16.582% |
| Telesis Bio, Inc. | -35.15 Million USD | 83.94% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 139.393% |
| Varex Imaging Corporation | 32.1 Million USD | 117.586% |
| Quipt Home Medical Corp. | 3.91 Million USD | 244.042% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 53.474% |
| Pulmonx Corporation | -61.93 Million USD | 90.886% |
| Dynatronics Corporation | -2.27 Million USD | -148.345% |
| Modular Medical, Inc. | -17.52 Million USD | 67.796% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 61.439% |
| Semler Scientific, Inc. | 22.25 Million USD | 125.364% |
| InMode Ltd. | 195.66 Million USD | 102.885% |
| Bruker Corporation | 436.9 Million USD | 101.292% |
| Cytosorbents Corporation | -31.2 Million USD | 81.912% |
| DexCom, Inc. | 597.7 Million USD | 100.944% |
| Align Technology, Inc. | 643.33 Million USD | 100.877% |
| Viveve Medical, Inc. | -21.55 Million USD | 73.809% |
| ZimVie Inc. | -30.93 Million USD | 81.754% |
| Movano Inc. | -29.69 Million USD | 80.987% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 79.727% |
| Nexalin Technology, Inc. | -5.69 Million USD | 0.901% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -60.006% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 97.58% |
| Profound Medical Corp. | -28.61 Million USD | 80.273% |
| Insulet Corporation | 220 Million USD | 102.566% |
| enVVeno Medical Corporation | -25.23 Million USD | 77.633% |
| iCAD, Inc. | -7.68 Million USD | 26.583% |
| Nuwellis, Inc. | -17.63 Million USD | 67.981% |
| Biotricity, Inc. | -8.82 Million USD | 36.058% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 95.49% |
| Aethlon Medical, Inc. | -12.63 Million USD | 55.328% |
| InspireMD, Inc. | -21.14 Million USD | 73.301% |
| PAVmed Inc. | -68.79 Million USD | 91.794% |
| BIOLASE, Inc. | -17.93 Million USD | 68.529% |
| Beyond Air, Inc. | -63 Million USD | 91.041% |
| FONAR Corporation | 16.53 Million USD | 134.139% |
| AxoGen, Inc. | -21.46 Million USD | 73.698% |
| Vivani Medical, Inc. | -26.96 Million USD | 79.065% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 131.29% |
| Inari Medical, Inc. | -14.03 Million USD | 59.771% |
| UFP Technologies, Inc. | 57.66 Million USD | 109.789% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -14.559% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 10.479% |
| Tenon Medical, Inc. | -15.72 Million USD | 64.106% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 24.472% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 86.782% |
| AdaptHealth Corp. | -598.4 Million USD | 99.057% |
| Sintx Technologies, Inc. | -13.35 Million USD | 57.741% |
| NanoVibronix, Inc. | -3.43 Million USD | -64.29% |
| Quanterix Corporation | -49.7 Million USD | 88.642% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 53.474% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -1377.749% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 98.312% |
| TransMedics Group, Inc. | -28.72 Million USD | 80.349% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 76.093% |
| NeuroMetrix, Inc. | -7.15 Million USD | 21.066% |
| Hyperfine, Inc. | -48.11 Million USD | 88.268% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 91.319% |
| Biomerica, Inc. | -6.36 Million USD | 11.34% |
| Bone Biologics Corporation | -9.42 Million USD | 40.127% |
| AVITA Medical, Inc. | -40.4 Million USD | 86.028% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 45.254% |
| Silk Road Medical, Inc | -59.27 Million USD | 90.476% |